All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out moreCreate an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lymphoma & CLL content recommended for you
Featured:
At this year’s European School of Haematology (ESH) ‘2nd How to Diagnose and Treat: Lymphoma’ conference, the Lymphoma Hub will host a virtual Satellite Symposium. Marie José Kersten, Amsterdam UMC, Amsterdam, NL, invites you to participate on Sunday, November 8, 2020, at 15:50–16:50 CET.
Marie José Kersten invites you to join the virtual Lymphoma Hub Satellite Symposium on Nov 8, 2020!
Marie José Kersten will be discussing the case of a patient with R/R DLBCL following treatment with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. She will be joined by Kieron Dunleavy, Francesc Bosch, and Astrid Pavlovsky, as well as Lymphoma Hub Chair Gilles Salles who will lead the symposium.